samedan logo
 
 
 
spacer
home > pmps > summer 2019 > planning your automation project
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Planning Your Automation Project

At the end of 2018, the Medicines and Healthcare products Regulatory Agency undertook a pharmacy-level recall of several batches of blood pressure and heart medication (valsartancontaining medicines) made by Mylan and Teva. This followed previous action across Europe recalling the same substance from Dexcel and Actavis. The precautionary measure was put in place to prevent any risk to patient safety after an impurity was identified as part of the manufacturing process.

When the stakes of manufacturing are so high, it is only natural to want to stick with tried and tested methods. Any issues that occur during the manufacturing process can have a significant impact on drug supply and patient care; for example, patients cannot just stop taking their blood pressure and heart medication.

However, incorporating automation equipment and software into the production line can lead to myriad benefits. A more robust, modern manufacturing approach can lead to fewer interruptions, fewer product failures, and greater confidence that drugs will meet clinical performance. While industries like automotive and aerospace have excelled in automation, many pharmaceutical companies are concerned that the technology is too complex a change.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Marketing Director by day, Jonathan Wilkins is also one of the most prolific Industry 4.0 writers in the industrial automation sector. A professional brand advocate and commercial marketing strategist, Jonathan has been part of the EU Automation team since its humble beginnings in 2009 and has over a decade of experience in marketing.
spacer
Jonathan Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals receives FDA approval

[Pamplona, September 16th, 2019] 3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organisation (CDMO) specialized in process development and GMP manufacturing of biologics, receives FDA approval after completing the Pre-Approval Inspection (PAI) conducted at the 3P drug substance manufacturing facility.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement